Xcout Intel
Avandra
Avandra Imaging is a medical technology company headquartered in Newport Beach, California, that connects clinical imaging workflows to support oncology research, regulatory-grade studies, and AI model development.
Subscribe to see Avandra’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Avandra at a glance
Avandra is a healthcare company headquartered in United States. Its most recent funding round, Series A, raised $17.5M in February 2025. Xcout tracks 5 named people at Avandra, including Ryan Tarzy (FOUNDER and CEO).
Avandra leadership
- Ryan TarzyFOUNDER and CEO
- Angela LiuHEAD of OPERATIONS
- Dave ShahHEAD of ENGINEERING
- Doug SummeHEAD of PRODUCT
- Jeanne ManaloHEAD of SCIENTIFIC INNOVATION
Avandra funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $17.5M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Avandra competitors
A few of Avandra's closest competitors — see the full list of competitors and alternatives →
QMENTA is an all-in-one governed imaging platform built by neuroscientists to manage clinical trial data and run artificial intelligence workflows. Headquartered in Boston, Massachusetts, the company helps remove delays from imaging stages in medical research.
Advantis Medical Imaging is a medical technology company headquartered in Eindhoven, Netherlands, that has developed the cloud-based Advantis Platform to redefine medical imaging.
NewVue is headquartered in Tampa, Florida, and operates in the hospitals and health care industry. The company offers a radiology orchestration platform designed to change how radiology and interpretation workflows are handled.
Concordare Trials is an AI software company headquartered in New York that builds tools for clinical research teams at academic medical centers.
Concerto HealthAI was a healthcare technology company that used artificial intelligence and real-world data to support drug development and precision medicine. It primarily served biopharmaceutical companies, helping them generate clinical evidence and identify or stratify patients, particularly in oncology.
Median Technologies provides medical imaging solutions and services for oncology clinical trials and patient care. The company partners with pharmaceutical, biotechnology, and contract research organizations to transform medical images into actionable data, and develops artificial intelligence-based Software as Medical Devices (SaMDs) for the early diagnosis of serious diseases such as lung and liver cancer.
Get Avandra's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Avandra? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Avandra in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access